Golden Green’s Inspire Medical Systems INSP Stock Holding History

Golden Green’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,262	Closed	-$237K	–	182
2020 Q4	$237K	Buy	+1,262	New	+$206K	0.22%	95

Other funds holding INSP

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Golden Green's INSP Position: Q1 2021 in Review

Golden Green sold out of Inspire Medical Systems (INSP) in Q1 2021, closing a stake of 1,262 shares — an estimated $237K sold.

Golden Green first reported a position in INSP in Q4 2020 and held it in 1 quarter. The position peaked at $237K in Q4 2020. 250 funds tracked by Wall St. Rank hold INSP as of Q1 2021.

Golden Green reported no remaining Inspire Medical Systems position as of Q1 2021 after selling out during the quarter.
Golden Green sold 1,262 Inspire Medical Systems shares in Q1 2021, an estimated $237K.
Golden Green first reported a position in Inspire Medical Systems in Q4 2020 and held it in 1 quarter.
Golden Green's Inspire Medical Systems position peaked at $237K in Q4 2020.
250 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2021.

Based on Golden Green's 13F filing for Q1 2021, filed 13 Apr 2021.